Market Reports Center

Global Human Micobiome Market Size, Status and Forecast 2019-2025


Report Details

Global Human Micobiome Market Size, Status and Forecast 2019-2025

SKU QYFEB281920
Category Life Sciences
Publisher QY Research
Pages 108
Published Feb-19
Request Discount Pay by Wire/Invoice

Description

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.

The research usually can last 8-10 years, so scale production will occur in 2018. Before then, the Human Micobiome companies have to continue deficit.
At present, global investment concentrates in US and Europe, US takes 70% market share and Europe takes 25% market share. There are a few manufacturers in the world and the market concentration is high. The top5 (investment in Human Micobiome) companies are Vedanta, Seres Therapeutics, Second Genome, Rebiocix, ActoGeniX. The five companies occupy about 70% of the market share.
In 2018, the global Human Micobiome market size was 170 million US$ and it is expected to reach 820 million US$ by the end of 2025, with a CAGR of 21.7% during 2019-2025.

This report focuses on the global Human Micobiome status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Human Micobiome development in United States, Europe and China.

The key players covered in this study
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research Ltd
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics LLC

Market segment by Type, the product can be split into
Gastrointestinal Tract Human Micobiome
Urogenital Tract Human Micobiome
Other

Market segment by Application, split into
Treatment
Diagnosis

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Human Micobiome status, future forecast, growth opportunity, key market and key players.
To present the Human Micobiome development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Human Micobiome are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


News/Press Release

Table of Content

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Human Micobiome Market Size Growth Rate by Type (2014-2025)
1.4.2 Gastrointestinal Tract Human Micobiome
1.4.3 Urogenital Tract Human Micobiome
1.4.4 Other
1.5 Market by Application
1.5.1 Global Human Micobiome Market Share by Application (2014-2025)
1.5.2 Treatment
1.5.3 Diagnosis
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Human Micobiome Market Size
2.2 Human Micobiome Growth Trends by Regions
2.2.1 Human Micobiome Market Size by Regions (2014-2025)
2.2.2 Human Micobiome Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Human Micobiome Market Size by Manufacturers
3.1.1 Global Human Micobiome Revenue by Manufacturers (2014-2019)
3.1.2 Global Human Micobiome Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Human Micobiome Market Concentration Ratio (CR5 and HHI)
3.2 Human Micobiome Key Players Head office and Area Served
3.3 Key Players Human Micobiome Product/Solution/Service
3.4 Date of Enter into Human Micobiome Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Human Micobiome Market Size by Type (2014-2019)
4.2 Global Human Micobiome Market Size by Application (2014-2019)

5 United States
5.1 United States Human Micobiome Market Size (2014-2019)
5.2 Human Micobiome Key Players in United States
5.3 United States Human Micobiome Market Size by Type
5.4 United States Human Micobiome Market Size by Application

6 Europe
6.1 Europe Human Micobiome Market Size (2014-2019)
6.2 Human Micobiome Key Players in Europe
6.3 Europe Human Micobiome Market Size by Type
6.4 Europe Human Micobiome Market Size by Application

7 China
7.1 China Human Micobiome Market Size (2014-2019)
7.2 Human Micobiome Key Players in China
7.3 China Human Micobiome Market Size by Type
7.4 China Human Micobiome Market Size by Application

8 Japan
8.1 Japan Human Micobiome Market Size (2014-2019)
8.2 Human Micobiome Key Players in Japan
8.3 Japan Human Micobiome Market Size by Type
8.4 Japan Human Micobiome Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Human Micobiome Market Size (2014-2019)
9.2 Human Micobiome Key Players in Southeast Asia
9.3 Southeast Asia Human Micobiome Market Size by Type
9.4 Southeast Asia Human Micobiome Market Size by Application

10 India
10.1 India Human Micobiome Market Size (2014-2019)
10.2 Human Micobiome Key Players in India
10.3 India Human Micobiome Market Size by Type
10.4 India Human Micobiome Market Size by Application

11 Central & South America
11.1 Central & South America Human Micobiome Market Size (2014-2019)
11.2 Human Micobiome Key Players in Central & South America
11.3 Central & South America Human Micobiome Market Size by Type
11.4 Central & South America Human Micobiome Market Size by Application

12 International Players Profiles
12.1 Vedanta
12.1.1 Vedanta Company Details
12.1.2 Company Description and Business Overview
12.1.3 Human Micobiome Introduction
12.1.4 Vedanta Revenue in Human Micobiome Business (2014-2019)
12.1.5 Vedanta Recent Development
12.2 Seres Therapeutics
12.2.1 Seres Therapeutics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Human Micobiome Introduction
12.2.4 Seres Therapeutics Revenue in Human Micobiome Business (2014-2019)
12.2.5 Seres Therapeutics Recent Development
12.3 Second Genome
12.3.1 Second Genome Company Details
12.3.2 Company Description and Business Overview
12.3.3 Human Micobiome Introduction
12.3.4 Second Genome Revenue in Human Micobiome Business (2014-2019)
12.3.5 Second Genome Recent Development
12.4 Rebiotix
12.4.1 Rebiotix Company Details
12.4.2 Company Description and Business Overview
12.4.3 Human Micobiome Introduction
12.4.4 Rebiotix Revenue in Human Micobiome Business (2014-2019)
12.4.5 Rebiotix Recent Development
12.5 ActoGeniX
12.5.1 ActoGeniX Company Details
12.5.2 Company Description and Business Overview
12.5.3 Human Micobiome Introduction
12.5.4 ActoGeniX Revenue in Human Micobiome Business (2014-2019)
12.5.5 ActoGeniX Recent Development
12.6 Enterome BioScience
12.6.1 Enterome BioScience Company Details
12.6.2 Company Description and Business Overview
12.6.3 Human Micobiome Introduction
12.6.4 Enterome BioScience Revenue in Human Micobiome Business (2014-2019)
12.6.5 Enterome BioScience Recent Development
12.7 AvidBiotics
12.7.1 AvidBiotics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Human Micobiome Introduction
12.7.4 AvidBiotics Revenue in Human Micobiome Business (2014-2019)
12.7.5 AvidBiotics Recent Development
12.8 4D Pharma Research Ltd
12.8.1 4D Pharma Research Ltd Company Details
12.8.2 Company Description and Business Overview
12.8.3 Human Micobiome Introduction
12.8.4 4D Pharma Research Ltd Revenue in Human Micobiome Business (2014-2019)
12.8.5 4D Pharma Research Ltd Recent Development
12.9 Enterologics
12.9.1 Enterologics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Human Micobiome Introduction
12.9.4 Enterologics Revenue in Human Micobiome Business (2014-2019)
12.9.5 Enterologics Recent Development
12.10 Metabogen
12.10.1 Metabogen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Human Micobiome Introduction
12.10.4 Metabogen Revenue in Human Micobiome Business (2014-2019)
12.10.5 Metabogen Recent Development
12.11 Metabiomics
12.12 Ritter Pharmaceuticals
12.13 Osel
12.14 Symberix
12.15 Miomics
12.16 Symbiotix Biotherapies
12.17 MicroBiome Therapeutics LLC

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Figures

List of Tables and Figures

Table Human Micobiome Key Market Segments
Table Key Players Human Micobiome Covered
Table Global Human Micobiome Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Human Micobiome Market Size Market Share by Type 2014-2025
Figure Gastrointestinal Tract Human Micobiome Figures
Table Key Players of Gastrointestinal Tract Human Micobiome
Figure Urogenital Tract Human Micobiome Figures
Table Key Players of Urogenital Tract Human Micobiome
Figure Other Figures
Table Key Players of Other
Table Global Human Micobiome Market Size Growth by Application 2014-2025 (Million US$)
Figure Treatment Case Studies
Figure Diagnosis Case Studies
Figure Human Micobiome Report Years Considered
Table Global Human Micobiome Market Size 2014-2025 (Million US$)
Figure Global Human Micobiome Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Human Micobiome Market Size by Regions 2014-2025 (Million US$)
Table Global Human Micobiome Market Size by Regions 2014-2019 (Million US$)
Table Global Human Micobiome Market Share by Regions 2014-2019
Figure Global Human Micobiome Market Share by Regions 2014-2019
Figure Global Human Micobiome Market Share by Regions 2019
Table Market Top Trends
Table Global Human Micobiome Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Human Micobiome Market Share by Manufacturers (2014-2019)
Figure Global Human Micobiome Market Share by Manufacturers in 2018
Table Global Human Micobiome Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Human Micobiome Product/Solution/Service
Table Date of Enter into Human Micobiome Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Human Micobiome Market Size by Type (2014-2019) (Million US$)
Table Global Human Micobiome Market Size Share by Type (2014-2019)
Figure Global Human Micobiome Market Size Market Share by Type (2014-2019)
Table Global Human Micobiome Market Size by Application (2014-2019) (Million US$)
Table Global Human Micobiome Market Size Share by Application (2014-2019)
Figure Global Human Micobiome Market Size Market Share by Application (2014-2019)
Figure Global Human Micobiome Revenue Market Share by Application in 2018
Figure United States Human Micobiome Market Size 2014-2019 (Million US$)
Table United States Key Players Human Micobiome Revenue (2018-2019) (Million US$)
Table United States Key Players Human Micobiome Market Share (2018-2019)
Table United States Human Micobiome Market Size by Type (2014-2019) (Million US$)
Table United States Human Micobiome Market Share by Type (2014-2019)
Table United States Human Micobiome Market Size by Application (2014-2019) (Million US$)
Table United States Human Micobiome Market Share by Application (2014-2019)
Figure Europe Human Micobiome Market Size 2014-2019 (Million US$)
Table Europe Key Players Human Micobiome Revenue (2018-2019) (Million US$)
Table Europe Key Players Human Micobiome Market Share (2018-2019)
Table Europe Human Micobiome Market Size by Type (2014-2019) (Million US$)
Table Europe Human Micobiome Market Share by Type (2014-2019)
Table Europe Human Micobiome Market Size by Application (2014-2019) (Million US$)
Table Europe Human Micobiome Market Share by Application (2014-2019)
Figure China Human Micobiome Market Size 2014-2019 (Million US$)
Table China Key Players Human Micobiome Revenue (2018-2019) (Million US$)
Table China Key Players Human Micobiome Market Share (2018-2019)
Table China Human Micobiome Market Size by Type (2014-20189) (Million US$)
Table China Human Micobiome Market Share by Type (2014-2019)
Table China Human Micobiome Market Size by Application (2014-2019) (Million US$)
Table China Human Micobiome Market Share by Application (2014-2019)
Figure Japan Human Micobiome Market Size 2014-2019 (Million US$)
Table Japan Key Players Human Micobiome Revenue (2018-2019) (Million US$)
Table Japan Key Players Human Micobiome Market Share (2018-2019)
Table Japan Human Micobiome Market Size by Type (2014-2019) (Million US$)
Table Japan Human Micobiome Market Share by Type (2014-2019)
Table Japan Human Micobiome Market Size by Application (2014-2019) (Million US$)
Table Japan Human Micobiome Market Share by Application (2014-2019)
Figure Southeast Asia Human Micobiome Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Human Micobiome Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Human Micobiome Market Share (2018-2019)
Table Southeast Asia Human Micobiome Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Human Micobiome Market Share by Type (2014-2019)
Table Southeast Asia Human Micobiome Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Human Micobiome Market Share by Application (2014-2019)
Figure India Human Micobiome Market Size 2014-2019 (Million US$)
Table India Key Players Human Micobiome Revenue (2018-2019) (Million US$)
Table India Key Players Human Micobiome Market Share (2018-2019)
Table India Human Micobiome Market Size by Type (2014-2019) (Million US$)
Table India Human Micobiome Market Share by Type (2014-2019)
Table India Human Micobiome Market Size by Application (2014-2019) (Million US$)
Table India Human Micobiome Market Share by Application (2014-2019)
Figure Central & South America Human Micobiome Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Human Micobiome Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Human Micobiome Market Share (2018-2019)
Table Central & South America Human Micobiome Market Size by Type (2014-2019) (Million US$)
Table Central & South America Human Micobiome Market Share by Type (2014-2019)
Table Central & South America Human Micobiome Market Size by Application (2014-2019) (Million US$)
Table Central & South America Human Micobiome Market Share by Application (2014-2019)
Table Vedanta Company Details
Table Vedanta Revenue in Human Micobiome Business (2014-2019) (Million US$)
Figure Vedanta Revenue Growth Rate in Human Micobiome Business (2014-2019)
Table Vedanta Recent Development
Table Seres Therapeutics Company Details
Table Seres Therapeutics Revenue in Human Micobiome Business (2014-2019)(Million US$)
Figure Seres Therapeutics Revenue Growth Rate in Human Micobiome Business (2014-2019)
Table Seres Therapeutics Recent Development
Table Second Genome Company Details
Table Second Genome Revenue in Human Micobiome Business (2014-2019)(Million US$)
Figure Second Genome Revenue Growth Rate in Human Micobiome Business (2014-2019)
Table Second Genome Recent Development
Table Rebiotix Company Details
Table Rebiotix Revenue in Human Micobiome Business (2014-2019)(Million US$)
Figure Rebiotix Revenue Growth Rate in Human Micobiome Business (2014-2019)
Table Rebiotix Recent Development
Table ActoGeniX Company Details
Table ActoGeniX Revenue in Human Micobiome Business (2014-2019)(Million US$)
Figure ActoGeniX Revenue Growth Rate in Human Micobiome Business (2014-2019)
Table ActoGeniX Recent Development
Table Enterome BioScience Company Details
Table Enterome BioScience Revenue in Human Micobiome Business (2014-2019)(Million US$)
Figure Enterome BioScience Revenue Growth Rate in Human Micobiome Business (2014-2019)
Table Enterome BioScience Recent Development
Table AvidBiotics Company Details
Table AvidBiotics Revenue in Human Micobiome Business (2014-2019)(Million US$)
Figure AvidBiotics Revenue Growth Rate in Human Micobiome Business (2014-2019)
Table AvidBiotics Recent Development
Table 4D Pharma Research Ltd Company Details
Table 4D Pharma Research Ltd Revenue in Human Micobiome Business (2014-2019)(Million US$)
Figure 4D Pharma Research Ltd Revenue Growth Rate in Human Micobiome Business (2014-2019)
Table 4D Pharma Research Ltd Recent Development
Table Enterologics Company Details
Table Enterologics Revenue in Human Micobiome Business (2014-2019)(Million US$)
Figure Enterologics Revenue Growth Rate in Human Micobiome Business (2014-2019)
Table Enterologics Recent Development
Table Metabogen Company Details
Table Metabogen Revenue in Human Micobiome Business (2014-2019)(Million US$)
Figure Metabogen Revenue Growth Rate in Human Micobiome Business (2014-2019)
Table Metabogen Recent Development
Table Metabiomics Company Details
Table Ritter Pharmaceuticals Company Details
Table Osel Company Details
Table Symberix Company Details
Table Miomics Company Details
Table Symbiotix Biotherapies Company Details
Table MicroBiome Therapeutics LLC Company Details
Table Global Human Micobiome Market Size by Regions (Million US$) 2019-2025
Figure Global Human Micobiome Market Size Share by Regions (2019-2025)
Figure Global Human Micobiome Market Size Share by Regions in 2025
Figure United States Human Micobiome Market Size Forecast (2019-2025)(Million USD)
Figure Europe Human Micobiome Market Size Forecast (2019-2025)(Million USD)
Figure China Human Micobiome Market Size Forecast (2019-2025)(Million USD)
Figure Japan Human Micobiome Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Human Micobiome Market Size Forecast (2019-2025)(Million USD)
Figure India Human Micobiome Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Human Micobiome Market Size Forecast (2019-2025)(Million USD)
Table Global Human Micobiome Market Size by Product (2019-2025) (Million US$)
Figure Global Human Micobiome Market Size by Product (2019-2025)
Figure Global Human Micobiome Market Size by Product in 2025
Table Global Human Micobiome Market Size by Application (2019-2025) (Million US$)
Figure Global Human Micobiome Market Size by Application (2019-2025)
Figure Global Human Micobiome Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Market Reports Center © Copyright 2019 All rights reserved.

wire transfer
HDFC
ssl